Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK.
The Royal Marsden Hospital, 203 Fulham Rd, Chelsea, London, SW3 6JJ, UK.
Eye (Lond). 2023 Feb;37(3):415-420. doi: 10.1038/s41433-022-01952-4. Epub 2022 Jan 31.
The true disease status of a population with suspected microbial keratitis (MK) cannot be verified. There is not an accurate (gold) reference standard to confirm infection and inter-test comparisons of sensitivity and specificity therefore lead to bias with questionable estimates of test utility. We present an alternative method to report results.
We used a decision to treat as the definition for MK. We retrospectively compared the results of corneal culture and polymerase chain reaction (PCR) as these are objective tests available for the three principal groups of pathogens. We then estimated the potential contribution of positive results, either alone or in combination, to support the working diagnosis.
We included 2021 (77.4%) eyes with suspected bacterial keratitis, 365 (14.0%) with suspected acanthamoeba keratitis, and 226 (8.6%) with suspected fungal keratitis, all treated between July 2013 and December 2019. In these groups, there were 51.6% positive culture and 6.5% positive PCR results for bacteria, 19.0% and 40.5% for acanthamoeba, and 28.3% and 15.0% for fungi. Between groups the differences in the proportions of positive results from culture and PCR was statistically significant (P < 0.001). The added benefit of PCR to the result of culture in identifying a potential pathogen was 1.4% for bacteria (P = 0.6292), 24.4% for acanthamoeba (P = 0.0001), and 5.8% for fungi (P = 0.3853).
For suspected MK a comparison of the test positivity rate is an easily comprehensible outcome measure of test utility.
疑似微生物角膜炎(MK)人群的真实疾病状况无法得到验证。目前尚无准确的(金)参考标准来确认感染,因此,各检测方法间的敏感性和特异性比较会导致偏倚,从而使检测实用性的估计值受到质疑。我们提出了一种替代的报告结果方法。
我们将治疗决策作为 MK 的定义。我们回顾性比较了角膜培养和聚合酶链反应(PCR)的结果,因为这两种方法是针对三种主要病原体的客观检测方法。然后,我们估计了阳性结果(单独或组合)对支持临床诊断的潜在贡献。
我们纳入了 2021 只(77.4%)疑似细菌性角膜炎、365 只(14.0%)疑似棘阿米巴角膜炎和 226 只(8.6%)疑似真菌性角膜炎的患眼,这些患者均在 2013 年 7 月至 2019 年 12 月间接受了治疗。在这些组中,细菌培养的阳性率为 51.6%,PCR 的阳性率为 6.5%;棘阿米巴的阳性率分别为 19.0%和 40.5%;真菌的阳性率分别为 28.3%和 15.0%。各组间培养和 PCR 的阳性结果比例差异具有统计学意义(P<0.001)。PCR 对培养结果鉴定潜在病原体的附加益处分别为细菌 1.4%(P=0.6292)、棘阿米巴 24.4%(P=0.0001)和真菌 5.8%(P=0.3853)。
对于疑似 MK,检测阳性率的比较是一种易于理解的检测实用性的结果衡量指标。